1. Home
  2. FVRR vs CGEM Comparison

FVRR vs CGEM Comparison

Compare FVRR & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$21.43

Market Cap

754.2M

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.52

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
CGEM
Founded
2010
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
754.2M
671.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
FVRR
CGEM
Price
$21.43
$10.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
7
Target Price
$32.60
$27.14
AVG Volume (30 Days)
727.8K
1.2M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
139.40
N/A
EPS
0.61
N/A
Revenue
$427,401,000.00
N/A
Revenue This Year
$12.77
N/A
Revenue Next Year
$5.67
N/A
P/E Ratio
$35.46
N/A
Revenue Growth
12.68
N/A
52 Week Low
$19.36
$5.68
52 Week High
$36.11
$13.60

Technical Indicators

Market Signals
Indicator
FVRR
CGEM
Relative Strength Index (RSI) 51.47 58.44
Support Level $20.43 $10.01
Resistance Level $21.37 $13.33
Average True Range (ATR) 0.63 1.10
MACD 0.19 0.04
Stochastic Oscillator 76.39 48.98

Price Performance

Historical Comparison
FVRR
CGEM

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: